Literature DB >> 1352200

Effect of portacaval anastomosis on glutamine synthetase activities in liver, brain, and skeletal muscle.

G Girard1, R F Butterworth.   

Abstract

Glutamine synthetase is responsible for the ATP-dependent amidation of glutamate to glutamine. In liver the enzyme is highly localized in perivenous hepatocytes; in brain the enzyme is localized in astrocytes. Portacaval anastomosis resulted in liver atrophy, hyperammonemia, and up to 90% loss of glutamine synthetase activity in liver homogenates. This effect, which appears to be irreversible, probably reflects the selective loss of perivenous hepatocytes following portacaval anastomosis. Glutamine synthetase activities in brain were unaffected by portacaval anastomosis of up to 12 weeks' duration. Enzyme activities in homogenates of skeletal muscle, on the other hand, were significantly increased at one and four weeks after shunt surgery. These effects were not the result of decreased food intake in shunted animals. These findings suggest fundamentally different regulatory mechanisms for glutamine synthetase in these tissues. Skeletal muscle may thus provide an important alternative site for ammonia detoxification after portal-systemic shunting.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352200     DOI: 10.1007/bf01300297

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Portacaval shunt in the rat.

Authors:  S H LEE; B FISHER
Journal:  Surgery       Date:  1961-10       Impact factor: 3.982

2.  Enzymes of ammonia detoxication after portacaval shunt in the rat. II. Enzymes of glutamate metabolism.

Authors:  J P Colombo; C Bachmann; E Peheim; J Berüter
Journal:  Enzyme       Date:  1977

3.  Cerebrospinal fluid glutamine as a measure of hepatic encephalopathy.

Authors:  B T Hourani; E M Hamlin; T B Reynolds
Journal:  Arch Intern Med       Date:  1971-06

4.  The origin of alanine produced in skeletal muscle.

Authors:  T W Chang; A L Goldberg
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

5.  Glutamine synthetase activity in the organs of fed and 24-hours fasted rats.

Authors:  L Arola; A Palou; X Remesar; M Alemany
Journal:  Horm Metab Res       Date:  1981-04       Impact factor: 2.936

6.  Acute biochemical and histological effects of portacaval shunt in the normal rat.

Authors:  O L Meyers; R Hickman; M Keraan; G H Engelbrecht; B L Webber; J Terblanche
Journal:  S Afr Med J       Date:  1975-06-21

7.  Postoperative course after portacaval anastomosis in rats is determined by the portacaval pressure gradient.

Authors:  D L Coy; A Srivastava; J Gottstein; R F Butterworth; A T Blei
Journal:  Am J Physiol       Date:  1991-12

Review 8.  Ammonia: key factor in the pathogenesis of hepatic encephalopathy.

Authors:  R F Butterworth; J F Giguère; J Michaud; J Lavoie; G P Layrargues
Journal:  Neurochem Pathol       Date:  1987 Feb-Apr

9.  Cerebral ammonia metabolism in hyperammonemic rats.

Authors:  A J Cooper; S N Mora; N F Cruz; A S Gelbard
Journal:  J Neurochem       Date:  1985-06       Impact factor: 5.372

10.  Regional differences in the capacity for ammonia removal by brain following portocaval anastomosis.

Authors:  R F Butterworth; G Girard; J F Giguère
Journal:  J Neurochem       Date:  1988-08       Impact factor: 5.372

View more
  17 in total

Review 1.  Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy-therapeutic perspectives.

Authors:  Milan Holecek
Journal:  Metab Brain Dis       Date:  2013-08-31       Impact factor: 3.584

2.  Hyperammonemia in gene-targeted mice lacking functional hepatic glutamine synthetase.

Authors:  Natalia Qvartskhava; Philipp A Lang; Boris Görg; Vitaly I Pozdeev; Marina Pascual Ortiz; Karl S Lang; Hans J Bidmon; Elisabeth Lang; Christina B Leibrock; Diran Herebian; Johannes G Bode; Florian Lang; Dieter Häussinger
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

Review 3.  Oxidative stress in the pathogenesis of hepatic encephalopathy.

Authors:  M D Norenberg; A R Jayakumar; K V Rama Rao
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

4.  Effect of portacaval anastomosis on glutamine synthetase protein and gene expression in brain, liver and skeletal muscle.

Authors:  P Desjardins; K V Rao; A Michalak; C Rose; R F Butterworth
Journal:  Metab Brain Dis       Date:  1999-12       Impact factor: 3.584

5.  High ammonia diet: its effect on the glial fibrillary acidic protein (GFAP).

Authors:  G Bodega; I Suárez; M C Boyano; M Rubio; R M Villalba; E Arilla; L González-Guijarro; B Fernández
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

6.  Delivery of glutamine synthetase gene by baculovirus vectors: a proof of concept for the treatment of acute hyperammonemia.

Authors:  M A Torres-Vega; R Y Vargas-Jerónimo; A G Montiel-Martínez; R M Muñoz-Fuentes; A Zamorano-Carrillo; A R Pastor; L A Palomares
Journal:  Gene Ther       Date:  2014-10-23       Impact factor: 5.250

Review 7.  Effects of hyperammonaemia on brain function.

Authors:  R F Butterworth
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

8.  Effect of probenecid on 5-hydroxyindoleacetic acid in cisternal cerebrospinal fluid of rats with portacaval anastomosis.

Authors:  M Bergeron; M S Swain; E Molina-Holgado; T A Reader; R F Butterworth
Journal:  Neurochem Res       Date:  1995-08       Impact factor: 3.996

9.  L-ornithine-L-aspartate in experimental portal-systemic encephalopathy: therapeutic efficacy and mechanism of action.

Authors:  C Rose; A Michalak; P Pannunzio; G Therrien; G Quack; G Kircheis; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

10.  Keratinocytes as depository of ammonium-inducible glutamine synthetase: age- and anatomy-dependent distribution in human and rat skin.

Authors:  Lusine Danielyan; Sebastian Zellmer; Stefan Sickinger; Genrich V Tolstonog; Jürgen Salvetter; Ali Lourhmati; Dieter D Reissig; Cristoph H Gleiter; Rolf Gebhardt; Gayane Hrachia Buniatian
Journal:  PLoS One       Date:  2009-02-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.